Wilairatana P

References (3)

Title : Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights - Rezaul_2024_Brain.Res__148886
Author(s) : Rezaul Islam M , Akash S , Murshedul Islam M , Sarkar N , Kumer A , Chakraborty S , Dhama K , Ahmed Al-Shaeri M , Anwar Y , Wilairatana P , Rauf A , Halawani IF , Alzahrani FM , Khan H
Ref : Brain Research , :148886 , 2024
PubMedID: 38582413

Title : Neuroprotective evaluation of diospyrin against drug-induced Alzheimer's disease - Alam_2023_Fitoterapia_171_105703
Author(s) : Alam A , Ali G , Nawaz A , AlOmar TS , Rauf A , Ayaz M , Ahmad S , Almasoud N , AlOmar AS , Khalil AA , Wilairatana P
Ref : Fitoterapia , 171 :105703 , 2023
PubMedID: 37852388

Title : Evaluation of pyrimidine\/pyrrolidine-sertraline based hybrids as multitarget anti-Alzheimer agents: In-vitro, in-vivo, and computational studies - Javed_2023_Biomed.Pharmacother_159_114239
Author(s) : Javed MA , Jan MS , Shbeer AM , Al-Ghorbani M , Rauf A , Wilairatana P , Mannan A , Sadiq A , Farooq U , Rashid U
Ref : Biomed Pharmacother , 159 :114239 , 2023
PubMedID: 36638595